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Abstract  
 Helicobacter pylori has been associated with a number of 
gastrointestinal disorders including gastritis, peptic ulcer disease, gastric 
adenocarcinoma and gastric mucosa-associated lymphoid tissue (MALT) 
lymphoma. The present study was conducted to determine the prevalence of 
Helicobacter pylori infection among patients complaining from abdominal 
pain and visiting internal medicine clinics. It was also purposed to 
investigate the relationship between both age and sex with Helicobacter 
pylori infection. A retrospective study was conducted and included 
101patients with abdominal pain. The results showed that the prevalence of 
IgG against Helicobacter pylori infection is 85%, while about 38.6% of cases 
were positive for IgA against Helicobacter pylori. No significant 
relationships were found for IgG, IgA with age and sex (p value >0.05). 
Taken together, the study showed high prevalence of H. pylori infection 
among patients complaining of abdominal pain. H.pylori infection is not 
associated significantly with age and sex.  
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Introduction 
 From a microbiologic point of view, Helicobacter pylori (H. pylori) 
is classified as a gram negative, spiral shaped organism that colonizes the 
human gastric mucosa. H. pylori has a ubiquitous, worldwide distribution as 
it is claimed to be the commonest bacterial infection worldwide (Hunt, 
1996). It has the ability to colonize the acid secreting portion of the stomach 
where it remains for long period, possibly for life (Stein, 2002; Appelmelk, 
1998). 
 Helicobacter pylori infects over half the world’s population making it 
one of the most successful bacterial pathogens (Giudice, 2001). Several 
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studies have indicated that infection rates to be highest in developing 
countries and gastric colonization is usually lifelong unless infection is 
treated (Frenck, 2003; Miehlke, 1999).  
 Several studies suggested that persisting H.pylori infection in spite of 
a strong cellular and humoral immune response both locally and systemically 
is due to the fact that natural infection does not induce protective immunity. 
Furthermore, infections are asymptomatic in approximately 80% of 
individuals, however in the remaining 20% H. pylori infection is associated 
with a number of gastrointestinal disorders including gastritis, peptic ulcer 
disease, gastric adenocarcinoma and gastric mucosa-associated lymphoid 
tissue (MALT) lymphoma (Enno, 1998; Ernst, 2000; Correa; Uemura, 2001). 
 The H. pylori organism has the ability to colonize the human stomach 
and induces long-term infection of the gastric and duodenal mucosa in 
children and adults. It has been estimated that the majority of peptic ulcers 
and 85% of gastric adenocarcinomas and in over 95% of cases of gastric 
mucosa-associated lymphoid tissue (MALT) lymphoma are attributed to the 
infection by H.pylori (Tolia, 1999).  
 Furthermore, several researchers have conducted several 
epidemiologic studies in various geographical regions and found the early 
acquirement of this infection in life especially in developing countries 
(Ashorn, 1996; Thomas, 1993; Bitzan, 1998).  
 According to studies by Wu (2001) and Rowland (1999), infection 
with H. pylori occurs via oral ingestion of the bacterium and is transmitted 
primarily within families during early childhood. Other routes of infection 
include  direct transmission from person to person by saliva, vomit, or feces 
in industrialized countries (Wu, 2001; Parsonnet, 1999). 
 
Treatment of H.pylori 
 There are certain therapeutic options for treatment of H. pylori 
infection including a combination therapy with two different antibiotics 
together with a proton-pump inhibitor, which is in most cases successful in 
eradicating the bacteria and healing ulcers (Wong, 1999). 
 In several conditions, it required to test for H. pylori if there is peptic 
ulcer disease, low grade gastric MALT lymphoma, after endoscopic 
resection of early gastric cancer, if there are first degree relatives with gastric 
cancer, and in certain cases of dyspepsia (Stenström, 2008) not routinely. 
Several ways of testing exist. One can test noninvasively for H. pylori 
infection with a blood antibody test, stool antigen test, or with the carbon 
urea breath test (in which the patient drinks 14C- or 13C-labelled urea, 
which the bacterium metabolizes, producing labelled carbon dioxide that can 
be detected in the breath). However, the most reliable method for detecting 
H. pylori infection is a biopsy check during endoscopy with a rapid urease 
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test, histological examination, and microbial culture. There is also a urine 
ELISA test with a 96% sensitivity and 79% specificity. None of the test 
methods are completely failsafe. Even biopsy is dependent on the location of 
the biopsy. Blood antibody tests, for example, range from 76% to 84% 
sensitivity. Some drugs can affect H. pylori urease activity and give false 
negatives with the urea-based tests (Stenström, 2008; Kusters, 2006). 
 
Study objectives  
1- To determine the prevalence of H.pylori among patients complaining from 
abdominal pain. 
2- To investigate the relationship between the IgA and IgG with sex and age. 
 
Methods and Subjects 
 This is a retrospective study. We referred to files of patients visiting 
internal medicine clinics. Study sample included 101 patients complaining 
from abdominal pain. patients were screened for H.pylori using ELIZA. Both 
IgG and IgA were screened for all patients. Cases were considered positive 
for H.pylori if the titer for IgG or IgA is > 20.  
 Statistical analysis included descriptive methods such as frequencies 
and percentages to describe general characteristics of participants. Chi-
square test was used to explore the relationship between study variable with 
both IgG and IgA. Statistical significance was tested at alpha level < 0.05.  
 
Results  
Characteristics of participants 
 As shown in data presented in table 1, the study included 101 
participants. About 56% of participants were under the age of 35 years 
whereas about 44% of participants were more than 35 years. About 65% of 
participants were males while about 35% of participants were females. 
About 39% of cases were positive for IgA and about 85% of cases were 
positive for IgG (table 1). 
Table 1: General characteristics of participants 
Variable  Frequency  Percentage  
Age (years) 
<35 
> 35 
 
57 
44 
 
56.4 
43.6 
Sex  
Male 
female 
 
66 
35 
 
65.3 
34.7 
IgA 
Positive  
Negative  
 
39 
62 
 
38.6 
61.4 
IgG 
Positive  
Negative  
 
86 
15 
 
85.1 
14.9 
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 The relationship between IgA and study variables 
 The data presented in table 2 showed the relationship between IgA 
and both of age and sex. There were 22 cases (38.6%) positive for IgA under 
the age 35 years while there were 35 cases (61.4%) negative for IgA under 
35 years. The data showed there were 17 cases (38.6%) positive for IgA over 
35 years while there were 27 cases (61.4%) positive for IgA over 35 years. 
The relationship between IgA and age is not statistically significant (p value 
0.990). 
 The data showed that about 41% of males were positive for IgA 
while about 59% of males were negative for IgA. About 34% of females 
were positive for IgA while about 66% of females were negative for IgA. 
The relationship between IgA and sex is not statistically significant (p value 
0.515) (table 2). 
Table 2: the relationship between IgA and study variables 
variable          IgA P value 
Positive  Negative  
N (%) N (%) 
Age (years) 
<35 
>35 
 
22 (38.6) 
17 (38.6) 
 
35 (61.4) 
 
27 (61.4) 
0.99 
Sex  
Males 
 
Females  
 
27 (40.9) 
 
12 (34.3) 
 
39 (59.1) 
 
23 (65.7) 
0.515 
 
The relationship between IgG and study variables 
 As shown in table 3, 86% of participants under the age 35 years were 
positive for IgG, and 14% were negative for IgG under the same group. 
About 84% of participants were positive for IgG over 35 years and about 
16% were negative under the same age group. The relationship between IgG 
and age is not statistically significant (p value 0.793). 
 In regard to sex, about 85% of males and about 86% of females were 
positive for IgG. The relationship between sex and IgG is not statistically 
significant (p value 0.907). 
Table 3: The relationship between IgG and study variables 
variable                IgG P value 
Positive  Negative  
N (%) N (%) 
Age (years) 
<35 
>35 
 
49 (86) 
37 (84.1) 
 
8(14) 
7 (15.9) 
0.793 
Sex  
Males 
Females  
 
56 (84.8) 
30 (85.7) 
 
10 (15.2) 
5 (14.3) 
0.907 
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Discussion  
 Of 101 patient visiting internal medicine clinics of Prince Hamza ibn 
Hashim Hospital complaining from abdominal pain, 86 (85.1%) were 
positive for H.pylori (IgG). This finding is consistent with other studies 
(Tolia, 1999).  
 The data of the present study showed 39 cases (38.6%) were positive 
for IgA of H.pylori. our results are in line with other studies in which it has 
repeatedly been shown that the titers of IgA and IgG antibodies to H pylon in 
serum can be used as non-invasive tests for the presence of gastric Hpylon 
infection and gastritis (Kreuning, 1994).  
 It is not surprising to have no significant correlation between the 
titers of both IgG and IgA with age and sex (p value >0.05 for all). The 
reason is thought to be attributed to the clinical outcomes of the patients 
which are independent of age and sex.  
 Conclusions: the study showed high prevalence of H.pylori infection 
among patients complaining of abdominal pain. H.pylori infection is not 
associated significantly with age and sex.  
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